|
1
|
Innovation adoption in substance abuse treatment: exposure, trialability, and the Clinical Trials Network.
|
J Subst Abuse Treat
|
2007
|
2.88
|
|
2
|
Trends in the adoption of medications for alcohol dependence.
|
J Clin Psychopharmacol
|
2006
|
2.13
|
|
3
|
Service delivery in substance abuse treatment: reexamining "comprehensive" care.
|
J Behav Health Serv Res
|
2007
|
1.93
|
|
4
|
Patterns of organization and management in private and public substance abuse treatment programs.
|
J Subst Abuse Treat
|
2006
|
1.91
|
|
5
|
A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network.
|
J Subst Abuse Treat
|
2010
|
1.56
|
|
6
|
Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation.
|
Addict Behav
|
2011
|
1.55
|
|
7
|
Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions.
|
Subst Abus
|
2012
|
1.36
|
|
8
|
Counselor attitudes toward the use of motivational incentives in addiction treatment.
|
Am J Addict
|
2010
|
1.33
|
|
9
|
The adoption of alcohol pharmacotherapies in the Clinical Trials Network: the influence of research network participation.
|
J Subst Abuse Treat
|
2010
|
1.30
|
|
10
|
Availability of integrated care for co-occurring substance abuse and psychiatric conditions.
|
Community Ment Health J
|
2006
|
1.20
|
|
11
|
Individual and network factors associated with non-fatal overdose among rural Appalachian drug users.
|
Drug Alcohol Depend
|
2010
|
1.15
|
|
12
|
A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation.
|
J Stud Alcohol Drugs
|
2011
|
1.14
|
|
13
|
Organizational-level correlates of the provision of detoxification services and medication-based treatments for substance abuse in correctional institutions.
|
Drug Alcohol Depend
|
2008
|
1.02
|
|
14
|
Evidence-based treatment for opiate-dependent clients: availability, variation, and organizational correlates.
|
Am J Drug Alcohol Abuse
|
2006
|
1.01
|
|
15
|
Risky relationships: targeting HIV prevention for women offenders.
|
AIDS Educ Prev
|
2012
|
0.98
|
|
16
|
Disparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States.
|
J Stud Alcohol Drugs
|
2013
|
0.96
|
|
17
|
Timing of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages.
|
J Subst Abuse Treat
|
2011
|
0.94
|
|
18
|
Examination of an interventionist-led HIV intervention among criminal justice-involved female prisoners.
|
J Exp Criminol
|
2009
|
0.93
|
|
19
|
Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs.
|
J Subst Abuse Treat
|
2012
|
0.91
|
|
20
|
Introduction to the special issue on organizational dynamics within substance abuse treatment: a complex human activity system.
|
J Subst Abuse Treat
|
2011
|
0.88
|
|
21
|
Modified therapeutic communities and adherence to traditional elements.
|
J Psychoactive Drugs
|
2009
|
0.86
|
|
22
|
The relationship between Clinical Trial Network protocol involvement and quality of substance use disorder treatment.
|
J Subst Abuse Treat
|
2013
|
0.79
|
|
23
|
The availability of integrated care in a national sample of therapeutic communities.
|
J Behav Health Serv Res
|
2012
|
0.77
|
|
24
|
Racial differences in HIV/AIDS discussion strategies and sexual risk behaviors among drug-abusing female criminal offenders.
|
J Psychoactive Drugs
|
2008
|
0.77
|
|
25
|
Inmate Pre-Release Assessment (IPASS) Aftercare Placement Recommendation as a Predictor of Rural Inmate's 12-Step Attendance and Treatment Entry Post-Release.
|
J Offender Rehabil
|
2009
|
0.75
|
|
26
|
Change and Continuity at the Journal of Substance Abuse Treatment.
|
J Subst Abuse Treat
|
2016
|
0.75
|